Events & Presentations

Investors

Events & Presentations

Upcoming Events
Date Event Details Remind Me
Oct 18, 2019 8:00 AM EDT
Arrowhead Analyst R&D Day 2019
New York, NY
Archived Events
Date Event Details
Nov 30, 2016 8:30 AM EST
The 28th Annual Piper Jaffray Healthcare Conference
New York

November 30, 8:30 a.m. EST – Christopher Anzalone, Ph.D., Arrowhead president and CEO will deliver a corporate overview in a fireside chat with Ted Tenthoff, senior research analyst, Piper Jaffray.

Presentation Canceled

Nov 29, 2016 4:30 PM EST
Clinical Update Call
Nov 14, 2016 10:00 AM CST
American Heart Association's Scientific Sessions 2016
New Orleans

November 14, 10:40 a.m. CST – Stacey Melquist, Ph.D., Arrowhead senior scientist will deliver an oral presentation titled, “Targeting factor XII (F12) with a novel RNAi delivery platform as a prophylactic treatment for thromboembolism”

November 14, 2:00 p.m. CST – Stacey Melquist, Ph.D., Arrowhead senior scientist will deliver an oral presentation titled, “Targeting apolipoprotein(a) with a novel RNAi delivery platform as a prophylactic treatment to reduce risk of cardiovascular events in individuals with elevated lipoprotein (a)”

Nov 13, 2016
The Liver Meeting® 2016, the Annual Meeting of the American Association for the Study of Liver Disease
Boston

RNA interference therapeutic ARC-AAT prevents production of Z-alpha1 antitrypsin polymers and reverses liver disease phenotype in PiZ mouse model

  • Publication Number: 124
  • Session: Parallel 19: Pediatric and Metabolic Liver Diseases: Basic and Translational
  • Session Date and Time: November 13, 2016 from 4:45 PM to 6:15 PM
  • Authors: Christine Wooddell, et al.

RNA interference (RNAi) with ARC-AAT provides deep and prolonged knockdown of alpha-1 antitrypsin levels in healthy volunteers

  • Publication Number: LB-24
  • Session: Late-Breaking Poster Session
  • Session Date and Time: November 13, 2016 from 8:00 AM to 5:30 PM

Authors: Alice Turner, et al.

Nov 7, 2016 11:30 AM MST
The 25th Annual Credit Suisse Healthcare Conference
Scottsdale, AZ

November 7, 11:30 a.m. MST – Christopher Anzalone, Ph.D., Arrowhead president and CEO will deliver a corporate presentation.

Sep 29, 2016 6:00 AM PDT
Arrowhead/Amgen Collaboration Call
Sep 23, 2016 7:30 PM EDT
2016 International HBV Meeting
Seoul, Korea

September 24, 8:30 a.m. KST – Zhao Xu, Ph.D., Arrowhead senior scientist will deliver an oral presentation titled, “Functional HBsAg-encoding HBV fusion transcripts are produced from integrated HBV DNA in chronically infected chimpanzees - evidence from single molecule, real time (SMRT) sequencing”

Sep 14, 2016 4:30 PM EDT
7th Non-Coding RNA & RNAi Therapeutics Conference
Boston

September 14, 4:30 p.m. EDT – Erik Bush, Ph.D., Arrowhead director of extrahepatic targeting will deliver an oral presentation titled, “Targeted delivery strategies using Dynamic PolyconjugateTM (DPCTM) technology”

Sep 9, 2016 10:00 AM EDT
The 23rd Annual NewsMakers in the Biotech Industry
New York

September 9, 10:00 a.m. EDT – Christopher Anzalone, Ph.D., Arrowhead president and CEO will deliver a corporate presentation

Aug 9, 2016 4:30 PM EDT
Arrowhead Fiscal 2016 Third Quarter Results